medicine: aricept

aricept description

Go to trade names and prices








Donepezil (also misspelled donezepil), marketed under the trade name Aricept by its developer Eisai and partner Pfizer, is a centrally acting reversible acetylcholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine. Its binding to the acetylcholinesterase can be seen at Proteopedia 1eve. It has an oral bioavailability of 100% and easily crosses the blood-brain barrier. Because it has a half life of about 70 hours, it can be taken once a day. Initial dose is 5 mg per day, which can be increased to 10 mg per day after an adjustment period of at least 4 weeks.

Studies in Alzheimer's disease

Currently, there is no definitive proof that use of donepezil or other similar agents alters the course or progression of Alzheimer's disease. However, 6-12 month controlled studies have shown modest benefits in cognition and/or behavior, such as one published in 1999. Pilot studies have reported that donepezil therapy may potentially have effects on markers of disease progression, such as hippocampal volume. Therefore, many neurologists, psychiatrists, and primary care physicians use donepezil in patients with Alzheimer's disease. In 2005, the UK National Institute for Clinical Excellence (NICE) withdrew its recommendation for use of the drug for mild-to-moderate AD, on the basis that there is no significant improvement in functional outcome; of quality of life or of behavioral symptoms. However, NICE revised its guidelines to suggest that donepezil be used in moderate stage patients for whom the evidence is strongest. It is currently not licensed for Alzheimer's disease in the UK at any other stage.

While the drug is currently indicated for mild to moderate Alzheimer's, there is also evidence from 2 trials that it may be effective for moderate to severe disease. An example of this is a Karolinska Institute paper published in The Lancet in early 2006, which states that donepezil improves cognitive function even in patients with severe Alzheimer's disease symptoms.

Donepezil inhibiting Torpedo californica acetylcholinesterase. See Proteopedia 1eve.

Combinations

Donepezil is sometimes used in combination with memantine, a newer agent for Alzheimer's disease, as the response to both together is considered superior to donepezil alone. In moderate to severe Alzheimer's, a controlled clinical trial has shown that the addition of memantine to stable donepezil therapy improves cognition, functioning and behavior.

Uses for other conditions

Donepezil has been tested in other cognitive disorders (and is sometimes used off label) including Lewy body dementia and vascular dementia, but it is not currently approved for these indications. donepezil has been found to improve sleep apnea in Alzheimer's patients.

Donepezil has also been studied in patients with Mild Cognitive Impairment, schizophrenia, attention deficit disorder, post-coronary bypass cognitive impairment, cognitive impairment associated with multiple sclerosis, CADASIL, and Down syndrome. A 3 year NIH trial in patients with mild cognitive impairment reported that donepezil was superior to placebo in delaying rate of progression to dementia during the initial 18 months of the study but this was not sustained at 36 months. In a secondary analyses, a subgroup of individuals with the Apolipoprotein E4 genotype showed sustained benefits with donepezil throughout the study. However at this time donepezil is not indicated for prevention of dementia.

Recent studies suggest that donepezil can improve speech in children with autism. The studies found that speech of austistic children who were mild to moderately affected appeared to improve from the use of Donepezil.

Relationship to class and placebo

Donepezil is generally better tolerated than others in its class, simpler to use, and the agent with the most number of well controlled clinical trials. Common side effects include bradycardia, nausea, diarrhea, anorexia, abdominal pain, and vivid dreams. In 2006, Eisai, the manufacturer issued a statement that a single vascular dementia study found a difference in the percent of study participants who died in the donepezil group (1.7%) versus the placebo group (0%) and that this could be due to an unusually low death rate on the placebo group. An analysis of all three Vascular Dementia trials, according to Eisai, "shows no statistically significant differences in observed mortality rates between the donepezil and placebo groups (1.7% vs. 1.1%)". A physician has reported several cases of mania.

Use in the general population

In July 2002, a pilot study, reported that donepezil improves the memory of aging pilots. The researchers trained pilots in a flight simulator to perform specific maneuvers and to respond to emergencies that developed during their mock flight, after giving half the pilots donepezil and half a placebo. One month later they retested the pilots and found that those who had taken the donepezil remembered their training better, as shown by improved performance.

See also

Dimebon
memantine

Trade names

Trade names and prices of aricept

Name Information Price* Quantity
       
Aricept ODT 5mg 28 tablet (donepezil) $169 28 tablet
Aricept ODT 10mg 28 tablet (donepezil) $169 28 tablet
Aricept 5mg 100 tablets (donepezil) $428 100 tablets
Aricept 10mg 28 tablets (donepezil) $162 28 tablets
Generic Donepezil HCL 5mg 30 tablets (donepezil) $102 30 tablets
Generic Donepezil HCL 10mg 30 tablets $118 30 tablets

*) Prices related to some of online drugstores. There are only approximate prices. For some of drugs is needed a prescription.

Tags

Keywords related to aricept

follutein potassium chloride citanest trastuzumab teveten darodipine lasalocid phenylalanine doxy clidinium bromide dapiprazole microzide dioxaphetyl butyrate succinylsulfathiazole tapazole cytadren fenozolone lumiliximab salicylamide sodium sulamyd moxidectin agomelatine domeboro sulfamylon cefradine camazepam alinia pergolide vigamox fluticasone propionate nitrendipine calcitriol bucolome cinepazide isothipendyl delavirdine vytorin levocabastine aceburic acid fragmin rituxan syntex follistim sivelestat metolazone tredaptive clopidol amicar arprinocid arsenic trioxide nicodicodine isoprenaline floxin mepron etanercept clobenzepam tazobactam parlodel i p i chlorocresol


  • Related news


    Medivation Reports Third Quarter 2009 Financial Results and Provides
    dimebon to ongoing treatment with Aricept??, the leading Alzheimer's medication worldwide, on neuropsychiatric symptoms and activities of daily living. ...
    Read full article

    NHS ruling 'denies drugs to many'
    The manufacturer of one drug - Aricept - has been fighting a decision to restrict access to patients in the later stages of the disease. ...
    Read full article

    Drugs rationing body must release calculations
    Charities have been arguing for the drugs donepezil (Aricept), Eisai, which makes Aricept brought the case along with Pfizer, which co-market the drug. ...
    Read full article

    Dementia drug ban is flawed, say judges
    Aricept, which slows down the progress of Alzheimer's disease, is restricted for use only in patients with moderately severe symptoms. ...
    Read full article

    Pfizer and Eisai Continue Aricept Collaboration
    NEW YORK(BUSINESS WIRE)Pfizer Inc (NYSE: PFE) today announced that its agreement with Eisai to provide Aricept to patients suffering from Alzheimer's ...
    Read full article

    Eisai sees loss on MGI costs, but this year better
    Japan's fourth-largest drugmaker, best known for its Alzheimer's treatment Aricept, bought MGI this year for $3.9 billion, in a bold move for a company that ...
    Read full article

    Cambridge professor calls for healthy adults to use Ritalin 'to boost
    The Alzheimer's drug Aricept is among others which could bring huge benefits to healthy adults ranging from factory workers to surgeons, said Professor ...
    Read full article

    Pratchett criticises drugs ruling
    He now pays for his Aricept, which is prescribed to him by a specialist in Bath, But revised advice, published in November 2006, stated that Aricept ...
    Read full article

    Analyst awaits data on Wyeth-Elan Alzheimer's drug
    The Alzheimer's treatment market is led by four drugs: Pfizer Inc.'s Aricept, Forest Laboratories Inc.'s Namenda, Razadyne from Johnson & Johnson and Shire ...
    Read full article

    * Apotex tries to remove roadblocks to its Alzheimer's drug
    T> patents on Aricept, the world's No. 1 Alzheimer's disease treatment. A favorable ruling would pave the way for the US Food and Drug Administration to ...
    Read full article

    NICE must throw open the files on Alzheimer drug ruling
    The three anti-cholinesterase drugs Aricept, Exelon and Reminyl can only be prescribed for The drug firms Eisai, licence holder of Aricept, and Pfizer, ...
    Read full article

    Doctors Assail Growing Use of Antipsychotic Drugs for Dementia -
    Some experts say another group of medications antidementia drugs like Aricept, Exelon and Namenda are underused. Research shows that 10 to 20 percent of ...
    Read full article

    Eisai Is Confident of Aricept Sales Without Pfizer
    By Kanoko Matsuyama. May 14 (Bloomberg) -- Eisai Co. said it's confident about sales of its Aricept pill, the world's best-selling drug for Alzheimer's ...
    Read full article

    Scientists find key brain circuits for attention
    Existing drugs such as Aricept from Pfizer (PFE.N) and Eisai (4523.T), Exelon by Novartis (NOVN.VX) and Razadyne or Reminyl from Johnson & Johnson(JNJ. ...
    Read full article

    FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for
    FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review PR Newswire WOODCLIFF LAKE, NJ and NEW YORK, Nov. 24 WOODCLIFF LAKE, NJ and NEW YORK ...
    Read full article

    Eisai drug flunks Parkinson's trial
    In three years Eisai will lose patent protection for Aricept, a Alzheimer's drug which accounts for 40 percent of the company's sales. ...
    Read full article

    Japan's Eisai to hike div by 10 yen in 08/09-media
    Eisai, best known for its Alzheimer's treatment Aricept, has said it would post a net loss for the first time ever in 2007/08 on costs to acquire US cancer ...
    Read full article

    Lynda Bellingham hits out over Alzheimer's drugs failure
    She said: "Mum was put on Aricept, one of the new drugs that health chiefs Aricept, which improves memory and day-to-day life for Alzheimer's suffers, ...
    Read full article

    Eisai Says It Can End Pfizer Agreement on Aricept (Correct)
    By Naoko Fujimura and Catherine Larkin. May 9 (Bloomberg) -- Eisai Co., a Japanese drugmaker, said it will have the right to end its partnership with Pfizer ...
    Read full article

    FDA Approves Generic Aricept to Treat Dementia Related to Alzheimer's
    ROCKVILLE, Md., Dec. 16, 2009-The US Food and Drug Administration approved the first generic versions of. Aricept (donepezil hydrochloride) orally ...
    Read full article

    Eisai and Aricept Development Programs
    Eisai Co., Ltd. and Eisai Corporation of North America (Headquarters: Woodcliff Lake, NJ, Chairman and CEO Hajime Shimizu) are currently focusing on three ...
    Read full article

    Dementia patients set to get pills free Aricept, Exelon, Reminyl
    By EMMA MORTON. DRUG watchdogs face a massive climbdown after the Court of Appeal attacked their decision to ban 2.50-a-day drugs for thousands of ...
    Read full article

    Alzheimer's drug 'may also help victims of head injury to recover
    Donepezil, sold under the brand name Aricept, boosts levels of a brain chemical linked to Aricept suppresses a natural enzyme which normally breaks down ...
    Read full article

    Eisai to submit NDA for Aricept in Aug or Sept
    TOKYO, July 2 (Reuters) - Japanese drugmaker Eisai Co Ltd said on Thursday it plans to submit a new drug application (NDA) with the US Food and Drug ...
    Read full article

    Pfizer says study shows Lipitor has no significant impact on Alzheimer
    'In a study in patients with mild-to-moderate Alzheimer's disease (AD), the addition of Lipitor (atorvastatin calcium tablets) 80 mg to Aricept(R) ...
    Read full article

    US review finds no good drugs for dementia
    Four are in a class of drugs called cholinesterase inhibitors -- Pfizer and Eisai Co Inc's Aricept; galantamine, sold generically and under the brand names ...
    Read full article

    Author and Alzheimer's sufferer Terry Pratchett tells Bryan Appleyard
    Anger aside, Aricept and/or turmeric seems to be working for him. Aricept means he can't drink, but he's taken up snuff because it has an interesting ...
    Read full article

    Eisai Rises as Company Says It Can End Pfizer Pact
    The Tokyo-based maker of Aricept said May 9 it can end the promotion Eisai made 38 percent of its total sales from Aricept for the nine months ended Dec ...
    Read full article

    Eisai Launches New Oral Jelly Formulation of Aricept(R), World's
    Tokyo, Dec 1, 2009 - (JCN Newswire) - Eisai Co., Ltd. today announced the launch of a new formulation of its Alzheimer's disease (AD) treatment, Aricept(R) ...
    Read full article

    Eisai Seeks Approval to Sell Aricept Jelly in Japan
    By Jason Gale. March 14 (Bloomberg) -- Eisai Co., the maker of Aricept, the world's best-selling Alzheimer's disease drug, sought approval in Japan to sell ...
    Read full article

    Elan says trial of Alzheimer's vaccine restarted
    They include Aricept, sold by Pfizer Inc (PFE.N) and Eisai Co Ltd (4523.T). Shares of Elan were down 13 cents to $25.79 in early afternoon trading on the ...
    Read full article

    Banner, Sun Health institutes seeks patients for Alzheimer's study
    The study will evaluate the safety and effect of Dimebon taken in combination with Aricept, an FDA-approved Alzheimer's treatment. ...
    Read full article

    Generic Aricept Approved for Alzheimer's Dementia
    TUESDAY, Dec. 15 (HealthDay News) --Generic versions of the drug Aricept (donepezil hydrochloride) that will dissolve instantly on the tongue have been ...
    Read full article

    Eisai Shares Rise After Credit Suisse Analyst Upgrade
    The maker of Aricept Alzheimer's treatment reported a loss of 17 billion yen ($161 million) last year, its first since going public in 1961, ...
    Read full article

    Pfizer Gambles On Russian Alzheimer's Pill
    The deal makes sense for Pfizer, since it already co-markets the popular Alzheimer's drug Aricept, whose US patents expire in 2010. ...
    Read full article

    ASA: Donepezil (Aricept) Comes Up Short in Vascular Dementia Trials
    By Peggy Peck, Executive Editor, MedPage Today. NEW ORLEANS, Feb. 25 -- The Alzheimer's disease drug donepezil (Aricept) does not improve cognition in ...
    Read full article

    Patent Win Protects Eisai's Aricept Against Teva's Potential Generic
    * As noted in the Wall Street Journal article, Aricept is a blockbuster drug for the treatment of Alzheimer's disease. And, as noted in Judge Ackerman's ...
    Read full article

    Teva gets tentative FDA nod for generic Aricept
    LOS ANGELES, Jan 14 (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.O) said on Monday that the US Food and Drug Administration has granted tentative ...
    Read full article

    Alzheimer's drug fight goes before appeal court
    They are trying to overturn a NICE ruling that drugs like Aricept should not be Anti-cholinesterase drugs such as Aricept can help but not cure some ...
    Read full article

    Eisai's Aricept, Alzheimer's Rivals Fail to Get Wider UK Use
    By Michelle Fay Cortez. June 11 (Bloomberg) -- Eisai Co. failed to win expanded use for its best-selling Alzheimer's drug Aricept in Britain, ...
    Read full article

    What Is Aricept (Donepezil), How Does It Work and When Is It Used?
    Answer: Aricept is the brand name for donepezil. Donepezil is one of the cholinesterase inhibitors and overall it's the most widely prescribed drug for the ...
    Read full article

    1m won by drug company after NHS rationing mistake over Alzheimer
    The combination of Aricept, Exelon and Reminyl would have cost just 2.50 a day for each patient. Yesterday the court ruled that NICE must pay 60 per cent ...
    Read full article

    Teva Announces Tentative Approval Of Generic Aricept(R) Tablets
    Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the US Food and Drug Administration has granted tentative approval for the Company's ...
    Read full article

    Japan Hot Stocks-ABC-Mart, CSK, Eisai, JAL, oil-related shares
    citing the fact that the company's Aricept Alzheimer's drug will not receive approval from the US Food and Drug Administration for pediatric use and ...
    Read full article

    Alzheimer's Disease
    Other medicines include donepezil (Aricept), rivastigmine (Exelon), Aricept is taken once a day and may stabilize or even improve the person's mental ...
    Read full article

    Eisai Wins Appeal Ruling to Block Generic Aciphex
    Aciphex, first approved by US regulators in 1999, is Tokyo-based Eisai's second-biggest drug, behind the best-selling Alzheimer's treatment Aricept. ...
    Read full article

    Eisai granted favourable ruling in Aricept lawsuit
    TOKYO, March 29 (Reuters) - Eisai Co (4523.T: Quote, Profile, Research) said on Saturday it had been granted a favourable preliminary injunction ruling by a ...
    Read full article

    The Government's aim of early diagnosis and treatment of dementia is
    However, she was refused treatment with Aricept because her dementia is not severe enough and was not offered any other treatment or support. ...
    Read full article

    Light therapy can slow dementia
    ""Although 5% may not sound like a huge amount, it compares well with treatments such as Aricept designed to slow the progression of the illness. ...
    Read full article